Lenalidomide in Relapsed or Refractory Classical Hodgkin Lymphoma

Clinical trial NCT00540007 · COMPLETED

Trial details

NCT number: NCT00540007
Sponsor: Washington University School of Medicine
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hodgkin Disease

Start date: 2007-09-06
Primary completion: 2016-09-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.